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Abstract
Subcellular localization and transactivation of human hepatitis B virus X protein (HBx), a plausible causative factor for
hepatocellular carcinogenesis, were studied in transiently transfected cells. The transactivation was detected not only by the
cis-element driven chloramphenicol acetyltransferase (CAT) assay but also by immunostaining of CAT protein cotransfected
into human hepatoma cell line HepG2. Scanning fluorescence microscopy showed the majority of immunological signals of
HBx to be at the perinuclear region of transfected cytoplasm. HBx was also clearly detectable in the nucleus, though less
intensely expressed. This was confirmed by Western analysis and coimmunoprecipitation of HBx with transcription factor
IIB (TFIIB) in subcellular fractionations. The percentage of HBx-positive cells coincided with that of CAT-positive cells, and
confocal laser microscopy revealed the coexistence of CAT signals in GFP-HBx positive cells. The SV40 large T antigen
nuclear localization signal (NLS) appended HBx, regardless of whether NLS was added to the N- or C-terminus,
transactivated all the examined X-responsive elements (XRE) similarly as did wild-type HBx. Similar results were obtained in
p53 negative Saos-2 cells. The detected nuclear HBx may be involved in modulating the transcription at the promoter level
whereas the HBx in cytoplasm may be working through signal transduction pathways. ß 1999 Elsevier Science B.V. All
rights reserved.
Keywords: Hepatitis B virus X protein; Transactivation; Immunostaining; Subcellular localization; Transfection
1. Introduction
Human hepatitis B virus (HBV) induces acute and
chronic hepatitis, and is closely associated with the
incidence of human liver cancer [1]. Virally encoded
X protein (HBx) has been thought to be a major risk
factor for the development of human hepatocellular
carcinoma. However, the exact function of HBx in
the tumorigenic transformation of liver cells is still
unclear [2^4]. Since a long latent period is necessary
for the development of liver tumors after HBV in-
fection, activation or inactivation of host cellular
factors including proto-oncogenes and/or tumor sup-
presser genes has been proposed in relation to the
HBx activity [5^9].
HBx protein, encoded in the smallest open reading
frame (ORF) of the HBV genome, transcriptionally
transactivates not only viral but also a wide variety
of host cellular promoter elements known as X-re-
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sponsive elements (XRE) [10^15]. Many cellular fac-
tors have been proposed as possible targets for HBx
transactivation [16^23] including human RPB5, a
common subunit of RNA polymerase I, II and III
[24,25]. We and others discovered the binding of
HBx with transcription factor IIB (TFIIB), and sug-
gested the direct modulation of transcriptional con-
trol by a trimeric interaction of RNA polymerase
subunit, TFIIB and HBx [23^26]. Meanwhile, HBx
is observable in association with p53 tumor suppress-
er in hepatocellular carcinoma [6,27], and has been
discovered to bind directly with p53 [28,29]. HBx,
however, has no obvious nuclear localization signal
motif and has been detected preferentially in cyto-
plasm especially in the perinuclear region in experi-
mental cells and in human specimens [30^32]. In oth-
er reports, however, HBx has been detected in both
nuclear and cytoplasmic regions although the major
signals were found in cytoplasm [9,33], or predomi-
nantly in nucleus [26]. Woodchuck hepatitis virus X
protein (WHx), which is analogous to HBx, was also
detected not only as soluble protein in cytoplasm but
also as rather stable forms associated with nuclear
matrix [34]. Thus, subcellular localization of HBx is
still controversial.
In this study, we examined the subcellular local-
ization of HBx in relation to its transactivation ac-
tivity. HepG2, a human hepatoma cell line, and
p53-negative Saos-2 cells were employed. After co-
transfection with HBx expression vector and a chlor-
amphenicol acetyltransferase (CAT) reporter, cells
were stained immunologically with anti-HBx or
with anti-CAT. Serial scanning £uorescence micros-
copy was applied for the detection of HBx. More
than 80% of HBx-positive cells carried immunos-
tained £uorescent signals in the nuclear region
although these were weak in comparison with cyto-
plasmic signals. Confocal laser scanning observation
was applied to examine the localization of HBx in
cells cotransfected with GFP-HBx- and FLAG-
tagged TFIIB, which is restricted in nucleus. Another
immunological approach combined with cell fractio-
nation and coimmunoprecipitation experiments was
employed to examine the subcellular localization.
The transacting activity of HBx was also examined
by CAT assay. Colocalization of HBx and CAT pro-
tein in the same cell was con¢rmed by confocal ob-
servation using GFP-HBx and CAT staining.
2. Materials and methods
2.1. Cells, culture and transfection
One day before the transfection, 5^6U105 HepG2,
a human hepatoma cell line, were plated in 60-mm
culture dishes. Transfection was performed for 20 h
in 3% CO2/air at 37‡C followed by 24 h recovery in
5% CO2/air at 37‡C [35]. For the immunostaining,
1U105 cells were plated on a slide glass, settled into
a Quadriperm microscope slide culture well (Her-
aeus, Hanau, Germany). Saos-2, a p53 negative hu-
man osteosarcoma cell line, was also examined.
2.2. Plasmid constructions
The 154 amino acid full HBx coding sequence
was inserted into mammalian expression vector
pSG5UTPL (pSGHX-1) [12,36,37]. The polymerase
chain reaction (PCR) cloning method was employed
to add the SV40 nuclear localization signal (NLS)
sequence to the 5P- or 3P- ends of HBx, giving
NLS-X with MLPKKKRKV (pSGNLS-X), and
X-NLS with LPKKKRKV (pSGX-NLS), respec-
tively. By using the EcoRI and BamHI sites of a
vector pNCFLAG, pNCFLAG-HBx or pNCFLAG-
TFIIB encoding HBx or TFIIB with a Flag-tag both
at the N- and C-termini were constructed. CAT re-
porter pHECU2CAT has a dimeric sequence of the
23 bp HBV Enh-1 core. Other CAT reporters were
pNF-kBU3CAT, pTREU3CAT and pSRECAT
containing NF-kB binding site, AP-1 binding site
of TPA responsive element and serum-responsive el-
ement of the regulatory sequence of c-fos gene, re-
spectively [12,22,36,37]. All the constructed plasmids
were con¢rmed after cloning with a DNA sequencer
(370A; Applied Biosystems). An expression vector of
green £uorescent protein (GFP)-tagged HBx, pGFP-
HBx, was constructed by inserting the EcoRI and
BglII fragment harboring the full size of HBx into
the EcoRI and BamHI sites of pGFP [38]. pGFP-
TFIIB was also constructed in a similar way.
2.3. Immunostaining and CAT assay
The IgG fractions of rabbit anti-HBx, prepared in
our laboratory by using GST-fused proteins, were
puri¢ed by a two-step a⁄nity chromatography [25].
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Properly diluted (1:10) anti-HBx IgG fraction (30
Wg/ml) with 0.5% bovine serum albumin (BSA) was
absorbed with acetone-powdered nontransfected con-
trol cells (1:1 volume, 4‡C overnight) in phosphate-
bu¡ered saline (PBS). Commercially available rabbit
anti-CAT IgG (5 PrimeC3 Prime, Boulder, CO) was
also absorbed thoroughly.
Cells were ¢xed for 5 min with a freshly prepared
cold (325‡C) one-to-one mixture of acetone and
methanol, and then were stored at 380‡C in the
dried condition. Samples blocked with 1% BSA in
PBS were stained with diluted antibody (at 1/100)
for 2 h. Immunostaining was carried out by using
biotinylated goat anti-rabbit IgG and streptavidin-
FITC (Amersham Japan, Tokyo) following the mak-
er’s manual with counterstaining by 0.0005% Evans
Blue. For the observation, a superresolution scan-
ning Cellscan system (Scanalytics, Billerica, MA)
[39] mounted on a Zeiss Axioskop £uorescence mi-
croscope (Jena, Germany) equipped with a plan-neo-
£uor 40U or plan-apochromat 63U lens and a nar-
row blue band pass ¢lter set (BP485-20/FT510/
BP515-565), or confocal laser scanning microscope
(Zeiss Model LSM510 system), were used. An Olym-
pus BX-50 £uorescence microscope (Tokyo, Japan)
was also used with ¢lters of NIBA and WIB.
Scanned images were visualized by digital printing
(Pictrography 3000, Fuji, Tokyo, Japan).
The CAT assays were processed for 60 min at
37‡C using 20 Wg protein of cell lysates [12,36,37].
Activities of the CAT were determined as the per-
centage of acetylated conversion of [14C]chloram-
phenicol (Amersham) using a bioimage analyzer
(BAS1000; Fuji). Three independent assays were per-
formed for each experiment.
2.4. Western and coimmunoprecipitation blotting
HepG2 cells transfected with pNCFLAG-HBx or
pSG5UTPL were homogenized in bu¡er A (10 mM
Hepes^KOH (pH 7.9) at 4‡C, 1.5 mM MgCl2, 10 mM
KCl, 0.5 mM DTT) by 15 strokes with a Kontes
Dounce homogenizer using a B-type pestle. After
separation of the cytosol fraction by centrifugation,
the nuclear pellet was washed three times with bu¡er
A. The nuclear fraction was extracted with bu¡er C
(20 mM Hepes^KOH (pH 7.9) at 4‡C, 25% glycerol,
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF,
0.5 mM DTT and 420 mM NaCl) at 4‡C, then col-
lected by centrifugation [40]. All the fractions of the
cell extract were divided into aliquots and stored at
380‡C.
Cell extracts fractionated by sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) were transferred onto nitrocellulose mem-
branes, which were then cut into two pieces accord-
ing to the molecular mass markers, and Western
blotted using antibodies to detect FLAG-HBx and
actin, respectively. Monoclonal anti-FLAG (M2)
and anti-actin antibodies were purchased from Ko-
dak (New Haven, CT) or Oncogene (Uniondale,
NY). Results were visualized by horseradish peroxi-
dase-conjugated antimouse IgG and enhanced chemi-
luminescence (ECL, Amersham) according to the
maker’s instructions.
Nuclear extracts were immunoprecipitated with
rabbit anti-TFIIB raised in our laboratory as anti-
HBx. Coimmunoprecipitation was processed as de-
scribed previously [25]. The precipitated proteins
were eluted, fractionated by SDS^PAGE, Western
blotted by anti-FLAG and visualized as described
above.
3. Results
3.1. Transactivation by wild and modi¢ed HBx
Transactivation activity of HBx was examined by
CAT assay in a human hepatoma cell line, HepG2
(Fig. 1). Reportedly, HBx transactivated all of the
viral and cellular cis-elements including NF-kB-bind-
ing site, TPA-responsive element and the serum-re-
sponsive element. The classical nuclear localization
signal (NLS) of SV40 T antigen was introduced
into the HBx sequence [41]. Regardless of whether
the NLS was added to the N- or C-terminus of HBx,
both NLS-X and X-NLS transactivated all the XRE
including the NF-kB binding site and AP-1 binding
site of TPA responsive element (Fig. 1). No signi¢-
cant di¡erence in transactivation activity was ob-
served between wild-type and NLS appended HBx.
Thus the transactivation activity of HBx was not
altered by the addition of the classical NLS motif.
For cis-element speci¢city of HBx, mutated CAT
reporters having two-basepair substitutions in the
BBADIS 61814 22-3-99 Cyaan Magenta Geel Zwart
T. Nomura et al. / Biochimica et Biophysica Acta 1453 (1999) 330^340332
promoter region of Enh1 core were provided. Nei-
ther the HBx nor NLS appended HBx transactivated
the mutated reporters (not shown). We then chose
the HBV Enh1 core sequence as an example for the
later experiments.
3.2. Immunological detection of HBx in transfected
cells
Subcellular localization of HBx was examined by
immunostaining of cells after the appropriate trans-
fection. As described in Section 2, all the antibody
was absorbed thoroughly with nontransfected cells to
avoid nonspeci¢c reactions. No positive cells were
detected with preimmune serum in any samples
(not shown).
By superresolution scanning £uorescence micros-
copy, immunologically HBx-positive cells were ob-
vious in HBx-transfected samples and no signal was
detected in the control transfection (Fig. 2a,c). FITC
signals by immunostaining were clearly distinguished
from counterstaining with Evans Blue, by which cel-
lular or nuclear pro¢les were visualized in an inte-
grated image picture. Signals with HBx were much
more intense at the perinuclear region of cytoplasm
than the nucleus. In some cases, granular signals
scattered throughout the cytoplasm and/or organized
signals along the periphery of the cells were observed
(Fig. 2b). Granular or dotted HBx stainings at the
nuclear region were di⁄cult to de¢ne whether they
were in the nuclei or at the apical periphery of the
nuclei. Thus a serial scanning with a horizontal op-
tical cut at 0.82-Wm intervals was applied to deter-
mine the localization of the signals on the same re-
gion of Fig. 2a. Signal granules in the nuclear region
in Fig. 2a were con¢rmed to be inside the nuclei (Fig.
3). A vertical section analysis also revealed the exact
position of HBx in the nuclei (not shown). HBx-pos-
itive cells in NLS-appended pSGNLS-X or pSGX-
NLS transfection bore the signals preferentially in
their nuclei (Fig. 2e). Few cytoplasmic signals, how-
ever, were also detected in some cells (Fig. 2d). Sig-
nals with NLS-X or X-NLS transfection were weaker
than that with wild-type HBx; presumably the ap-
pended NLS sequence a¡ected the antigen^antibody
recognition, since transactivation of CAT reporter
was not altered with NLS-X or X-NLS (Fig. 1)
and CAT protein was detectable in staining (Fig. 6).
Fig. 1. Transactivation of cis-elements by HBx. HepG2 cells
were transfected with the HBx-expression vector indicated (1
Wg), pSG5UTPL (4 Wg) and a CAT-reporter (5 Wg). CAT activ-
ities measured with an image analyzer 2 days after transfection
are presented as the conversion rate (percentage) of acetylated
[14C]chloramphenicol. The HBx plasmids pSGHX-1, pSGNLS-
X and pSGX-NLS, harbor wild-type HBx, NLS-X and X-NLS,
respectively. Reporter plasmid pHECU2CAT has the HBV
Enh-1 core sequence, while pNF-kBU3CAT, pTREU3CAT
and pSRECAT carry NF-kB binding site, AP-1 binding site of
TPA responsive element and serum responsive element of the
regulatory sequence of c-fos gene, respectively.
Fig. 2. Integrated image of immunostaining with anti-HBx.
HepG2 cells cotransfected with HBx constructs and pHE-
CU2CAT were ¢xed with cold (325‡C) acetone/methanol
(1:1), cultured on slide glass and immunostained with anti-HBx
as described in Section 2. Imaging photographs were taken by
integrating serial scanning information analyzed by a Cellscan
system mounted on a £uorescence microscope with a plan apo-
chromatic U63 objection lens. (a,b) Samples transfected with
pSGHX-1 and pHECU2CAT. Bar = 9.1 Wm and 15.3 Wm, re-
spectively. (c) Sample transfected with pSG5UTPL and pHE-
CU2CAT. Bar = 19.7 Wm. (d) Sample transfected with NLS-
HBx and pHECU2CAT. Bar = 7.0 Wm. (e) Sample transfected
with HBx-NLS and pHECU2CAT. Bar = 10.7 Wm.
BBADIS 61814 22-3-99 Cyaan Magenta Geel Zwart
T. Nomura et al. / Biochimica et Biophysica Acta 1453 (1999) 330^340 333
3.3. Detection of HBx in fractions of transfected cell
lysates
In these experiments, we used anti-FLAG mono-
clonal antibody because of its high sensitivity in
Western analysis. HepG2 cells were transfected
with pNCFLAG-HBx or with empty vector. Cell ex-
tracts were fractionated into cytosol and nuclear
fractions as described in Section 2. HBx localization
was examined by Western blotting with anti-FLAG
and anti-actin for detection of cytosolic contamina-
tion on the same ¢lter (Fig. 4a). FLAG-HBx was
detected in both cytosol and nuclear fractions (lanes
1 and 3) but in neither fraction from the control
transfection (lanes 2 and 4). Approximately, one-
tenth of FLAG-HBx was detected in nuclear extract.
Since the sole cytosol protein, actin, could not be
detected in the nuclear extracts (lanes 3 and 4) even
with long exposure, the possibility of contamination
by cytosolic HBx of the nuclear fraction could be
excluded.
Further, nuclear localization of HBx was con-
¢rmed by coimmunoprecipitation of FLAG-HBx
with endogenous TFIIB (Fig. 4b). Nuclear extracts
were at ¢rst immunoprecipitated by anti-TFIIB and
subsequently blotted with anti-FLAG. Anti-FLAG
Fig. 4. Western blotting of FLAG-tagged HBx in cell fractions and coimmunoprecipitation. The molecular mass markers are indicated
in kDa. (a) HepG2 cells were transfected with pNCFLAG-HBx (fX) or pSG5UTPL (v). Cell extracts were fractionated into cytosol
and nuclear fractions as described in Section 2. The fractions of cell extract were separated by SDS^PAGE. Membrane was blotted
with anti-actin antibody (upper panel), or anti-FLAG antibody (lower panel). The nuclear extracts were derived from threefold the
number of cells used for cytosol fractions. FLAG-HBx and actin bands are indicated by arrowheads. (b) Nuclear extracts were immu-
noprecipitated with rabbit anti-TFIIB antibody (lane 3), anti-GST antibody (lane 2) and anti-FLAG (lane 4). Lane 1, 25% of the nu-
clear extract used in immunoprecipitation. The eluted proteins were fractionated by SDS^PAGE and Western blotted by anti-FLAG.
The asterisks indicate the mouse IgG heavy and light chains recognized by the second antibody.
Fig. 3. Serial scanning of HepG2 cells immunostained with anti-HBx. Serial scanning image of 50 horizontal optical sections of Fig.
2a shown in the same direction. Six sections, numbers 21 to 26, are shown from the top.
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and anti-GST were used as positive and negative
controls, respectively. FLAG-HBx was detectable in
the fraction immunoprecipitated with anti-TFIIB
(lane 3) and not with anti-GST (lane 2). These bio-
chemical results con¢rmed the nuclear localization of
HBx in HepG2 cells.
3.4. Colocalization of HBx and TFIIB in nucleus
To con¢rm the nuclear localization of HBx, we
examined the colocalization of HBx and the nuclear
protein, TFIIB, by cotransfection of pNKFLAG-
TFIIB and pGFP-HBx. Immunostaining of FLAG
by Texas Red (TexRd) was clearly distinguished
from green £uorescence of GFP-HBx by using a con-
focal microscope equipped with a Nomarski di¡er-
ential-interference-contrast apparatus.
Almost all FLAG-TFIIB was detected in nuclei of
the transfected cells (Fig. 5a) whereas the GFP-HBx
was in the nuclei and/or cytoplasm (Fig. 5b,c). In
some cases, GFP-HBx colocalized with FLAG-
TFIIB was observed in the nuclei of the cotrans-
fected cells (Fig. 5d^f). Overlaying the images of
FLAG-TFIIB (red) and GFP-HBx (green) and the
Nomarski image provided overlapped signals (yel-
low) in the nuclear region. In other cases, however,
HBx was detected in nuclei and/or cytoplasm inde-
pendently from TFIIB (Fig. 5g^i). In order to con-
¢rm these results, GFP-TFIIB was applied for the
cotransfection with HBx (Fig. 5j^l). Perinuclear ac-
cumulation of HBx was clear in this picture. The
detected nuclear HBx may correlate with the inter-
action of HBx and transcription components re-
cruited to promoters, whereas the HBx in cytoplasm
may be working to modulate signal transduction
pathways.
3.5. Detection of induced CAT protein by
immunostaining
Transactivation of HBx was also detected by the
immunostaining of resultant CAT protein using anti-
CAT serum. CAT-positive cells were observable in
the samples cotransfected with HBx constructs (Fig.
6), and only a few cells with extremely weak staining
were detected with control plasmid (Table 1a). There
was no di¡erence in the appearance of CAT protein
among the cotransfected HBx constructs.
3.6. Relationship between subcellular localization of
HBx and transactivation
Results of HBx immunostaining in HepG2 cells
are summarized in Table 1a. To monitor the trans-
fection e⁄ciency, pUC-LacZ was transfected and
Fig. 5. Confocal microscopic detection of HBx and TFIIB.
HepG2 cells were transfected with pNCFLAG-TFIIB (a), or
with pGFP-HBx (b,c), or both (d^i). Samples were stained with
anti-FLAG (M2) by Texas Red (a^i). HepG2 cells were trans-
fected pGFP-TFIIB together with pSGHX-1 (j^l). Samples were
stained with anti-HBx by Texas Red (j^l). (a) Image of anti-
FLAG staining (red) showing TFIIB. (b,c) GFP signals of
(green) showing HBx. (d) Image of anti-FLAG staining (red).
(e) GFP signals of the same cells cited in d (green). (f) Inte-
grated images of d,e and Nomarski di¡erential-interference-con-
trast image of the same cells in d and e. (g) Image of anti-
FLAG staining (red). (h) GFP signals of the same cells cited in
g (green). (i) Integrated images of g,h and Nomarski di¡eren-
tial-interference-contrast image. (j) Image of GFP signals
(green). (k) Image of anti-HBx staining of the same cells cited
in j (red). (l) Integrated images of j,k and Nomarski di¡eren-
tial-interference-contrast image.
BBADIS 61814 22-3-99 Cyaan Magenta Geel Zwart
T. Nomura et al. / Biochimica et Biophysica Acta 1453 (1999) 330^340 335
examined by staining with X-gal. Although transfec-
tion e⁄ciency £uctuates among experiments, X-gal
staining in this series of experiments was 3.3%. The
percentage of HBx-positive cells was calculated by
counting the signal-positive and negative cells (total
of 4000^10 000 cells) in randomly picked areas.
FITC-positive cells were categorized into three
groups by the signal localization in the cell. Regard-
less of the constructs used, more than 80% of HBx-
positive cells bore the signals in their nuclei with or
without cytoplasmic signals. Not only was the per-
centage of HBx-positive cells lower in the NLS-ap-
pended HBx, especially in NLS-HBx, but the signals
were weaker than those with wild-type HBx. Trans-
fection of HBx-NLS resulted in greater nuclear local-
ization and decreased cytoplasmic signals of HBx, so
that 94% of the positive cells exhibited nuclear sig-
nals. The percentage of CAT-positive cells in samples
prepared in parallel with NLS-HBx or HBx-NLS at
the same time was similar to or a little more than
that of wild-type HBx. The intensity of CAT signals
was also similar or a little increased in NLS ap-
pended HBx cotransfections.
To examine the relationship between CAT and
HBx, GFP-HBx and immunostaining of CAT by
TexRd were employed in cotransfections (Table 2).
Almost all CAT-positive cells (about 95%) carried
GFP-HBx, suggesting detected CAT signals are
products operated by the expressed GFP-HBx, which
is transacting active. No CAT-positive cells were ob-
served in control experiments without HBx and/or
without CAT transfection. Subcellular localization
of GFP signals in GFP/CAT-positive cells in Table
2 were nucleus, 16%; cytoplasm, 17.8%; both, 66.2%.
Fig. 7 shows the integrated confocal image of anti-
CAT staining (red), GFP signals (green) and Nomar-
ski di¡erential-interference-contrast. GFP signals are
Table 1
Summary of immunostaining
Transfection % X-positivea Locationc % CAT-positiveb
% nucleus % cytoplasm % both
(a) HepG2 cell
pSGHX-1 and pHECx2CAT 2.6 13.7 11.6 74.6 0.6
pSGNLS-X and pHECx2CAT 0.15 28.5 14.0 57.5 1.4
pSGX-NLS and pHECx2CAT 0.84 61.0 5.7 33.3 1.0
pSGHX-1 and pSG5UTPL ^ ^ ^ ^ 0
pHECx2CAT and pSG5UTPL 0 ^ ^ ^ 0.3
(b) Saos-2 cell
pSGHX-1 and pHECx2CAT 2.8 13.2 36.1 50.6 0.6
pSGNLS-X and pHECx2CAT 0.01 ^ ^ ^ 0.29
pSGX-NLS and pHECx2CAT 1.7 37.0 20.6 43.3 1.0
pHECx2CAT and pSG5UTPL 0 ^ ^ ^ 0.1
aPercentage of HBx-immunopositive cells over total cells scored in an area. 4^10U103 cells were counted in a dark ¢eld for an inde-
pendently chosen area.
bPercentage of CAT-immunopositive cells over total cells in an area. 4^10U103 cells were counted in a dark ¢eld for an independently
chosen area.
cDetailed localization of HBx signals in the immunopositive cells.
Fig. 6. Integrated image of immunostaining with anti-CAT.
HepG2 cells were ¢xed with cold acetone/methanol and immu-
nostained with anti-CAT as cited in Fig. 2 and Section 2. (a)
Transfected with pSGHX-1 and pHECU2CAT. Bar = 10.1 Wm.
(b) Transfected with NLS-HBx and pHECU2CAT. Bar = 13.3
Wm. (c) Transfected with HBx-NLS and pHECU2CAT.
Bar = 12.6 Wm. (d) Transfected with pSG5UTPL and pHE-
CU2CAT. Bar = 14.8 Wm.
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detectable in the nuclei (Fig. 7a) or perinuclear (Fig.
7b) whereas the expressed CAT protein distributes
throughout the cell. Regardless of the subcellular lo-
calization in nuclei or in cytoplasm, GFP-HBx trans-
activated the cotransfected CAT reporter. As men-
tioned previously, CAT staining was not detected in
cells transfected with CAT vector alone (data not
shown).
Nuclear localization of HBx protein and transacti-
vation were also examined in Saos-2 osteosarcoma
cells. Results are summarized in Table 1b. Funda-
mentally, no signi¢cant di¡erence in the distribution
of HBx was observed between HepG2 and Saos-2
cells. Reduction of HBx-positive cells, as in the
case of HepG2, was also observed on addition of
NLS to HBx, so that staining signals were rarely
detected in these transfections. The percentage of
CAT-positive cells did not di¡er between cotransfec-
tion with X-NLS and HBx.
4. Discussion
HBx is a multifunctional regulatory protein and
has been reported to be responsible for hepatocellu-
lar carcinogenesis. HBx transactivates not only viral
but also a variety of host cellular elements related to
cell proliferation and acute in£ammatory response
[10^15]. Several mechanisms of the transactivation
have been proposed, and HBx interacts with multiple
factors in nucleus and cytoplasm [16^26]. Subcellular
localization of HBx is still controversial. Woodchuck
WHx, which is analogous to HBx, has been observed
in cytosol and in nuclear matrix fractions [34]. HBx
in human specimens and in transient transfection ex-
periments has been reported to be localized in both
nucleus and cytoplasm [9,33] or in nucleus [26] or
cytoplasm [30^32].
In relation to the transactivation, we examined the
subcellular localization of HBx in transfected cells.
The pro¢le of our immunostaining showed HBx both
in nucleus and cytoplasm. Serial scanning analysis
con¢rmed the granular HBx signals in nucleus
although the majority of them were detected in the
perinuclear region of cytoplasm. Since very similar
results were obtained in samples ¢xed with 1.5% par-
aformaldehyde and treated with 0.2% Triton X-100,
the immunological signal pro¢le or distribution was
not in£uenced by the ¢xation treatments. In addition
to those cells having HBx signals exclusively in nuclei
or cytoplasm, cells carrying HBx both in nuclear and
cytoplasm were observed (classi¢ed as both). About
one-third of these cells have HBx signals mainly in
the nucleus. Western blotting analysis of the cell frac-
tionations revealed that the majority of expressed
HBx was recovered in the cytoplasmic fraction with
around 10% recovered in the nuclear fraction. E⁄-
cient recovery of HBx in the coimmunoprecipitates
with TFIIB, a sole nuclear protein, clearly supports
Fig. 7. Confocal microscopic detection of GFP-HBx and CAT
in double staining. HepG2 cells were transfected with pGFP-
HBx together with pHECU2CAT (a,b). Integrated confocal im-
age of anti-CAT stained by Texas Red (red) and GFP signals
(green) with Nomarski di¡erential-interference-contrast (a,b).
Table 2
Summary of GFP and CAT in staining of HepG2 cells
Transfection % GFP-positivea % CAT-positiveb CAT/GFP-positivec % GFP/CAT-positived
pGFPHx-1 and pHECx2CAT 5.0 2.1 39.7 94.9
pGFPUTPL and pHECx2CAT 1.2 0.1 0 ^
pGFPHx-1 and pSG5UTPL 2.9 0 0 ^
aPercentage of GFP-positive cells as cited in Table 1. bPercentage of CAT-positive cells as cited in Table 1. cPercentage of CAT-posi-
tive cells among GFP-positive cells. dPercentage of GFP-positive cells among CAT-positive cells.
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the notion that a minor but distinct portion of HBx
localizes in nucleus.
We addressed the e¡ect of NLS-tagging on subcel-
lular localization in transfected cells by examining a
large number of cells with several di¡erent methods.
The NLS-taggings had little e¡ect on delocalization
from cytoplasm and transactivation in HepG2, and
similar results were obtained in p53-negative Saos-2
cells. Since the HBx protein has no nuclear localiza-
tion signal motif, which is essential for translocation
of proteins through nuclear pores [41,44], HBx might
be introduced into nuclei by di¡usion or by protein^
protein interaction. This may explain the slight e¡ect
of the NLS tagging in our experiments. These results,
however, were di¡erent from others; NLS addition
severely impaired or abolished ability to transactivate
the NF-kB and AP-1 driven CAT reporters [31,33].
The reason for this discrepancy is unclear; however,
di¡erences in experimental conditions including sub-
type of HBx (ayw and adr), £anking amino acid
sequence of NLS, and recipient cells for transfection
may be responsible.
Our results with the HBx signal pro¢le and sub-
cellular localization are consistent with previous re-
ports [33] but di¡erent from results of exclusively
nuclear [26] or cytoplasmic localization [30^32]. A
possible transactivation mechanism involving cyto-
plasmic signal transduction pathways with protein
kinase C, Ras^Raf membrane activated protein kin-
ase and/or Src family of tyrosine kinases have been
proposed to be consistent with the exclusive cytoplas-
mic localization of HBx, and with the reduced trans-
activation by NLS-tagged HBx [7,33,42,43,45]. The
perinuclear or scattered signals of HBx in cytoplasm
in our study may relate to these possibilities or to the
colocalization of HBx with proteasome[31].
On the other hand, HBx has been discovered to
interact directly with several components of tran-
scription machinery including RPB5 of RNA poly-
merase, TATA box binding protein, and a general
transcription factor IIB [18^26]. These studies may
correlate with our biochemical and morphological
¢nding that some HBx signals are present in the
nucleus or nuclear fraction. It may be that parts of
the HBx enter the nucleus along with cellular factors.
We have compared the localization of HBx in co-
transfection with or without TFIIB. However, the
ratio of the cells with nuclear HBx was little a¡ected
by cotransfection with TFIIB (not shown). By the
confocal analysis of the cotransfected cells with the
HBx expression vector and a CAT reporter, the ac-
tivated expression of CAT was detected by immunos-
taining in HBx expressing cells. Regardless of nuclear
or cytoplasmic localization of HBx, CAT signals
were obvious in cells with HBx but not in those with-
out HBx, and were not detected in those transfected
with the reporter alone. Since, however, optical ob-
servation has limitations in the detection of speci¢c
protein, we cannot rule out the possibility that a
small amount of speci¢cally localized HBx may be
enough to make active host cellular elements.
Thus, HBx may have a dual role in transcriptional
activation. The cytoplasmic HBx may in£uence the
regulation of gene expression through signal trans-
duction pathways or through processing of other
proteins while the nuclear one may directly modulate
transcriptional machinery. In the latter case, HBx
interacts with polII complex through binding to
RPB5, recruiting TFIIB for transactivation, and at
the same time HBx antagonizes the repressor func-
tion of RMP, which is a novel regulator protein in-
teracting with RPB5 [46].
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